Breast cancer drug development - Listen - European Pharmaceutical

Breast cancer drug development

Listen now

Description

What unmet need remains in breast cancer and how is drug development helping tackle these challenges? Tune in to this episode with Daiichi Sankyo to find out more. Despite therapeutic advancement over the last few years, unmet need in breast cancer still remains. In this podcast, Professor Dr Markus Kosch, Head, Oncology Business Division Europe at Daiichi Sankyo, discusses the challenges associated with breast cancer treatment and some of the recent therapeutic developments that may help overcome them - highlighting the potential role of antibody-drug conjugates (ADCs).

More Episodes

See all »

FAIR Data in Pharma – Giovanni Nisato, Pistoia Alliance

Published 05/29/24

Developing modifier gene therapy

Ocugen is utilising the modifier gene therapy technology approach to treat retinal diseases. The therapy can be used to treat both inherited disorders, such as retinitis pigmentosa (RP), Leber congenital amaurosis, and Stargardt disease, but also multifactorial diseases like dry age-related...

Published 04/30/24

Inspiring inclusion in pharma

In this podcast, recorded ahead of International Women’s Day, Biogen’s Dr Kylie Bromley reflects on her career in the pharmaceutical sector and shares valuable insight into how the industry can work together to build greater gender equality and diversity.

Published 02/27/24